Ciprofloxacin and Erythema multiforme - a phase IV clinical study of FDA data
Summary:
We study 16,253 people who have side effects when taking Ciprofloxacin. Erythema multiforme is found, especially among people who are female, 60+ old, have been taking the drug for < 1 month, also take Pantoprazole and have Pain.
The phase IV clinical study analyzes which people take Ciprofloxacin and have Erythema multiforme. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
16,253 people reported to have side effects when taking Ciprofloxacin.
Among them, 217 people (1.34%) have Erythema multiforme.
What is Ciprofloxacin?
Ciprofloxacin has active ingredients of ciprofloxacin. It is used in urinary tract infection. Currently, eHealthMe is studying from 17,438 Ciprofloxacin users.
What is Erythema multiforme?
Erythema multiforme (a type of hypersensitivity reaction) is found to be associated with 2,770 drugs and 2,838 conditions by eHealthMe. Currently, we are studying 53,930 people who have Erythema multiforme.
Number of Ciprofloxacin and Erythema multiforme reports submitted per year:
Time on Ciprofloxacin when people have Erythema multiforme *:
Gender of people who have Erythema multiforme when taking Ciprofloxacin*:
Age of people who have Erythema multiforme when taking Ciprofloxacin *:
Common drugs people take besides Ciprofloxacin *:
Common side effects people have besides Erythema multiforme *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Ciprofloxacin and have Erythema multiforme?
Check whether Erythema multiforme is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Bolognesi M, Bolognesi D, "Medicine Ciprofloxacin-induced paroxysmal atrial fibrillation", , 2014 Mar .
- Bolognesi M, Bolognesi D, "Ciprofloxacin-induced paroxysmal atrial fibrilation", OA Case Reports, 2012 Jan .
- Tognetti L, Giorgini S, Lotti T, "Erythema multiforme-like eruption from a slimming drug preparation cutaneous adverse drug reaction", Indian dermatology online journal, 2011 Jan .
Related studies
Ciprofloxacin side effects by duration, gender and age:
- Ciprofloxacin side effects (17,438 reports)
Erythema multiforme treatments and more:
- Erythema multiforme (53,930 reports)
Common drugs associated with Erythema multiforme:
- Lopurin: 2,844 reports
- Allopurinol: 2,664 reports
- Lamictal: 2,554 reports
- Bextra: 2,312 reports
- Ibuprofen: 2,199 reports
- Profen: 2,199 reports
- Ibu: 2,199 reports
- Lamotrigine: 1,913 reports
- Omeprazole: 1,886 reports
- Furosemide: 1,861 reports
All the drugs that are associated with Erythema multiforme:
- Erythema multiforme (2,770 drugs)
Common conditions associated with Erythema multiforme:
- High blood pressure: 2,697 reports
- Epilepsy: 1,791 reports
- Fever: 1,640 reports
- Pain: 1,618 reports
All the conditions that are associated with Erythema multiforme:
- Erythema multiforme (2,838 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on ciprofloxacin (the active ingredients of Ciprofloxacin) and Ciprofloxacin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Advil and Ponstel drug interaction - a second ago
- Cartia Xt and Pred Forte drug interaction - 16 seconds ago
- Empagliflozin and Prochlorperazine Maleate drug interaction - 19 seconds ago
- Duoneb and Desonide drug interaction - 34 seconds ago
- Amlodipine Besylate and Pomalidomide drug interaction - 37 seconds ago
- Valium and Bradypnea - 46 seconds ago
- Aredia and Menstrual Disorder - 56 seconds ago
- Pacerone and Rheumatoid Arthritis - 57 seconds ago
- Methylprednisolone Sodium Succinate and Moxifloxacin drug interaction - 58 seconds ago
- Neulasta and Interstitial Lung Disease - a minute ago